NCT00098826 2013-01-11SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic SyndromesNational Cancer Institute (NCI)Phase 1 Completed40 enrolled